Clinical Trial Update: Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated three infusion regimens of IV conivaptan for euvolemic or hypervolemic hyponatremia and posted efficacy and safety results in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hyponatremia | Phase 3 | Status: COMPLETED | Results posted: 2010-04-21